SWOT Analysis Strength: The myocardial infarction market has witnessed considerable research and development in the past decade. Three major companies have developed novel drugs to treat myocardial infarction. Several clinical trials have proven the efficacy and safety of these new drug entities. Weakness: The treatment landscape remains dominated by generics due to patent expiries of...
Pulmonary Edema Therapeutics Market
Pulmonary Edema Therapeutics Market Projected to Grow Steadily with a CAGR of 3.3% by 2031
The global Pulmonary Edema Therapeutics Market is anticipated to witness substantial growth, registering a commendable CAGR of 3.3% throughout the forecast period spanning from 2024 to 2031. Pulmonary edema, a condition characterized by an excess accumulation of...
Medical Management of Pulmonary EdemaInitial treatment focuses on stabilizing the patient and includes supplemental oxygen, medication administration, and careful fluid management. Specific therapies may include:- Diuretics: Loop diuretics like furosemide work rapidly to increase urine output and eliminate excess fluid from the lungs and body. They remain a first-line treatment.- Vasodilators:...
Market Dynamics:
One of the major drivers for the growth of the myocardial infarction market is the increasing incidences of cardiovascular diseases globally. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death across the world. Every year 17.9 million people die from CVDs, which represent 31% of all global deaths. High blood...